uniQure to axe jobs and consolidate operations in cost-saving measures
Gene therapy firm uniQure will consolidate its global manufacturing and cut up to 60 jobs in a bid to recue operating expenses.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs